Clinical Outcome Assessments Toolbox for Radiopharmaceuticals

Authors

Charles A. Kunos
Jacek Capala
Adam P. Dicker
Benjamin Movsas, Henry Ford HealthFollow
Susan P. Ivy
Lori M. Minasian

Recommended Citation

Kunos CA, Capala J, Dicker AP, Movsas B, Ivy SP, and Minasian LM. Clinical outcome assessments toolbox for radiopharmaceuticals. Front Oncol 2019; 9.

Document Type

Article

Publication Date

1-1-2019

Publication Title

Front Oncol

Abstract

For nearly 40 years, the U.S. National Cancer Institute (NCI) has funded health-related quality-of-life (HRQOL) and symptom management in oncology clinical trials as a method for including a cancer patient's experience during and after treatment. The NCI's planned scope for HRQOL, symptom and patient-reported outcomes management research is explained as it pertains to radiopharmaceutical clinical development. An effort already underway to support protocol authoring via an NCI Cancer Therapy Evaluation Program (CTEP) Centralized Protocol Writing Service (CPWS) is described as this service aids incorporation of HRQOL, symptom and patient-reported outcomes management research into sponsored protocols.

PubMed ID

31649885

Volume

9

First Page

1028

Last Page

1028